 Risk Assessment
"Risk Assessment" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences. (Last, Dictionary of Epidemiology, 1988)
| Descriptor ID |
D018570
|
| MeSH Number(s) |
E05.318.740.600.800.715 N04.452.871.715 N05.715.360.750.625.700.690 N06.850.505.715 N06.850.520.830.600.800.715
|
| Concept/Terms |
Risk Assessment- Risk Assessment
- Assessments, Risk
- Risk Assessments
- Health Risk Assessment
- Assessment, Health Risk
- Assessments, Health Risk
- Health Risk Assessments
- Risk Assessment, Health
- Risk Assessments, Health
- Assessment, Risk
Benefit-Risk Assessment- Benefit-Risk Assessment
- Assessment, Benefit-Risk
- Assessments, Benefit-Risk
- Benefit Risk Assessment
- Benefit-Risk Assessments
- Risk-Benefit Assessment
- Assessment, Risk-Benefit
- Assessments, Risk-Benefit
- Risk Benefit Assessment
- Risk-Benefit Assessments
|
Below are MeSH descriptors whose meaning is more general than "Risk Assessment".
Below are MeSH descriptors whose meaning is more specific than "Risk Assessment".
This graph shows the total number of publications written about "Risk Assessment" by people in this website by year, and whether "Risk Assessment" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 | | 1996 | 0 | 4 | 4 | | 1997 | 1 | 5 | 6 | | 1998 | 0 | 3 | 3 | | 1999 | 0 | 6 | 6 | | 2000 | 1 | 7 | 8 | | 2001 | 0 | 6 | 6 | | 2002 | 1 | 18 | 19 | | 2003 | 1 | 28 | 29 | | 2004 | 3 | 35 | 38 | | 2005 | 4 | 53 | 57 | | 2006 | 6 | 39 | 45 | | 2007 | 5 | 54 | 59 | | 2008 | 10 | 70 | 80 | | 2009 | 5 | 91 | 96 | | 2010 | 3 | 102 | 105 | | 2011 | 9 | 113 | 122 | | 2012 | 5 | 127 | 132 | | 2013 | 16 | 79 | 95 | | 2014 | 18 | 129 | 147 | | 2015 | 17 | 123 | 140 | | 2016 | 19 | 120 | 139 | | 2017 | 24 | 157 | 181 | | 2018 | 19 | 132 | 151 | | 2019 | 30 | 153 | 183 | | 2020 | 21 | 143 | 164 | | 2021 | 14 | 114 | 128 | | 2022 | 1 | 34 | 35 | | 2023 | 1 | 32 | 33 | | 2024 | 0 | 3 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Risk Assessment" by people in Profiles.
-
Bateman DN, Dart RC, Dear JW, Prescott LF, Rumack BH. Fifty years of paracetamol (acetaminophen) poisoning: the development of risk assessment and treatment 1973-2023 with particular focus on contributions published from Edinburgh and Denver. Clin Toxicol (Phila). 2023 Dec; 61(12):1020-1031.
-
Savonitto S, Morici N, Pancani S, Nozza A, Cosentino F, Perrone Filardi P, Cavallini C, Angeli F, St?hli BE, Heerspink HJL, Mannini A, Schwartz GG, Lincoff AM, Tardif JC, Grobbee DE. Impact of age on the predictive value of NT-proBNP in patients with diabetes mellitus stabilised after an acute coronary syndrome. Diabetes Res Clin Pract. 2024 Feb; 208:111112.
-
Alderuccio JP, Reis IM, Hamadani M, Nachiappan M, Leslom S, Kahl BS, Ai WZ, Radford J, Solh M, Ardeshna KM, Hess BT, Lunning MA, Zinzani PL, Stathis A, Carlo-Stella C, Lossos IS, Caimi PF, Han S, Yang F, Kuker RA, Moskowitz CH. PET/CT Biomarkers Enable Risk Stratification of Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma Enrolled in the LOTIS-2 Clinical Trial. Clin Cancer Res. 2024 01 05; 30(1):139-149.
-
Titus BR, Ream KS, Rehman T, Allen LA. Sex-disparities in chest pain workup: a retrospective cohort review of a university based clinical decision pathway. BMC Cardiovasc Disord. 2023 12 19; 23(1):620.
-
Behari J, Bradley A, Townsend K, Becich MJ, Cappella N, Chuang CH, Fernandez SA, Ford DE, Kirchner HL, Morgan R, Paranjape A, Silverstein JC, Williams DA, Donahoo WT, Asrani SK, Ntanios F, Ateya M, Hegeman-Dingle R, McLeod E, McTigue K. Limitations of Noninvasive Tests-Based Population-Level Risk Stratification Strategy for Nonalcoholic Fatty Liver Disease. Dig Dis Sci. 2024 Feb; 69(2):370-383.
-
Kobayashi D, Amin EK, Morgan GJ, Reddy SRV, Fleming GA, Forbes TJ, Nykanen DG. Usefulness of PREDIC3T Case Type Risk Category in the CRISP Registry. Am J Cardiol. 2024 Feb 01; 212:73-79.
-
Simmons KM, Sims EK. Screening and Prevention of Type 1 Diabetes: Where Are We? J Clin Endocrinol Metab. 2023 Nov 17; 108(12):3067-3079.
-
Clements TW, Van Gent JM, Menon N, Roberts A, Sherwood M, Osborn L, Hartwell B, Refuerzo J, Bai Y, Cotton BA. Use of Low-Titer O-Positive Whole Blood in Female Trauma Patients: A Literature Review, Qualitative Multidisciplinary Analysis of Risk/Benefit, and Guidelines for Its Use as a Universal Product in Hemorrhagic Shock. J Am Coll Surg. 2024 Mar 01; 238(3):347-357.
-
Wortzel HS, Simonetti JA, Knoepke CE, Simpson JR, Brar L, Westmoreland P, Matarazzo BB. Extreme Risk Protection Orders: Legislative Intent and Clinician Guidance. J Psychiatr Pract. 2023 11 01; 29(6):480-488.
-
Blue L, Kranker K, Markovitz AR, Powell RE, Williams MV, Pu J, Magid DJ, McCall N, Steiner A, Stewart KA, Rollison JM, Markovich P, Peterson GG. Effects of the Million Hearts Model on Myocardial Infarctions, Strokes, and Medicare Spending: A Randomized Clinical Trial. JAMA. 2023 10 17; 330(15):1437-1447.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|